- OBE2109 is a GnRH receptor antagonist currently in development as both a stand-alone treatment and with add-back therapy designed to address the needs of endometriosis and uterine fibroid patients - ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback